A carregar...
The status of Her2 amplification and Kras mutations in mucinous ovarian carcinoma
Jayson GC et al. remarked in Lancet that nearly 100% of mucinous ovarian cancer cases have Kras mutation as well as a high frequency of Her2 amplification. Using the Abbott PathVysion Her2 DNA Probe Kit and Kras mutant-enriched PCR Kits (FemtoPath®), 21 samples of primary ovarian mucinous cystadenoc...
Na minha lista:
| Publicado no: | Hum Genomics |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5192568/ https://ncbi.nlm.nih.gov/pubmed/28031051 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40246-016-0096-9 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|